{"DataElement":{"publicId":"2854926","version":"1","preferredName":"Protocol Agent Prior Hypersensitivity Ind-3","preferredDefinition":"the yes/no/unknown whether there is an existing hypersensitivity, a local or general reaction of an organism following contact with a specific allergen to which it has been previously exposed and to which it has become sensitized, to a therapeutic agent (drug, intervention therapy) used in a clinical trial protocol.","longName":"2854924v1.0:2018845v1.0","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2854924","version":"1","preferredName":"Protocol Agent Prior Hypersensitivity","preferredDefinition":"information relating to an existing hypersensitivity, a local or general reaction of an organism following contact with a specific allergen to which it has been previously exposed and to which it has become sensitized, to a therapeutic agent (drug, intervention therapy) used in a clinical trial protocol.","longName":"2390874v1.0:2604302v1.0","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2390874","version":"1","preferredName":"Protocol Agent","preferredDefinition":"A therapeutic agent (drug, intervention therapy) used in a clinical trial protocol.","longName":"C41161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protocol Agent","conceptCode":"C41161","definition":"A medical product, practice, or application that is tested in a clinical trial.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE52ECB4-C771-617F-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-08-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-08-19","modifiedBy":"ONEDATA","dateModified":"2005-08-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2604302","version":"1","preferredName":"Prior Hypersensitivity","preferredDefinition":"Earlier in time or order.:Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.","longName":"C25629:C3114","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hypersensitivity","conceptCode":"C3114","definition":"An immune response that occurs following exposure to an innocuous antigen, but that does not require the presence of preformed antibodies to the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2AA1DF09-4DC7-0A16-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-03-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-03-01","modifiedBy":"ONEDATA","dateModified":"2007-03-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65CB5B31-DEFC-774D-E040-BB89AD433143","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-03-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506034","version":"1","preferredName":"Yes No Unknown Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no/unknown.","longName":"YES_NO_UNKNOWN_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"7","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D05-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D0F-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"3241403","version":"1","preferredName":"Unknown","longName":"3241403","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A4499CFB-7A3A-DD4D-E040-BB89AD4307BF","latestVersionIndicator":"Yes","beginDate":"2011-05-27","endDate":null,"createdBy":"DWARZEL","dateCreated":"2011-05-27","modifiedBy":"MMADDINENI","dateModified":"2023-12-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C379D9D0-6D1A-CCDD-E040-BB89AD432590","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2548260","version":"1","preferredName":"Ind-3","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no/unknown.","longName":"C38148","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes, No, or Unknown Response","conceptCode":"C38148","definition":"A response or indicator that can have a value of yes, no, or unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"23801A33-5B13-534B-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2006-11-30","endDate":"2016-04-27","createdBy":"BIRNBAUA","dateCreated":"2006-11-30","modifiedBy":"TAYLORT","dateModified":"2020-10-02","changeDescription":"10.2.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Retired DBW 4-27-2016 per Tina Taylor approved by Dianne Reeves","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C379D9D0-6CF1-CCDD-E040-BB89AD432590","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TITARENI","dateModified":"2021-09-14","changeDescription":"3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. 3/35/2016 jk removed \"indeterminate\" value that was added in error. 7/7/2021wz: added ALT VM name for HOPE-CARE project.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811912","version":"1","longName":"Head and Neck","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104894","version":"1","longName":"GOG-0231D","context":"NRG"},{"publicId":"4171051","version":"1","longName":"RTOG-1016","context":"NRG"},{"publicId":"4171052","version":"1","longName":"RTOG-0920","context":"NRG"},{"publicId":"4171061","version":"1","longName":"RTOG-1010","context":"NRG"},{"publicId":"4104935","version":"1","longName":"RTOG-1221","context":"NRG"},{"publicId":"4104937","version":"1","longName":"RTOG-1306","context":"NRG"},{"publicId":"4104994","version":"1","longName":"RTOG-1201","context":"NRG"},{"publicId":"4104934","version":"1","longName":"RTOG-1216","context":"NRG"}]}],"AlternateNames":[{"name":"PR_ALG_RXN_STUDY_AGT_IND","type":"Context Short Name","context":"CTEP"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"2854924v1.0:2018845v1.0","type":"USED_BY","context":"NRG"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"Prior allergic reaction to st","type":"Preferred Question Text","description":"Prior allergic reaction to study agent","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Prior allergic reaction to study agents","url":null,"context":"CTEP"},{"name":"CRF Text3","type":"Alternate Question Text","description":"Does the patient have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to OSI-906 ","url":null,"context":"CTEP"},{"name":"CRF Text4","type":"Alternate Question Text","description":"Does the patient have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to MLN8237, including but not limited to established allergic reaction to benzodiazepines?","url":null,"context":"CTEP"},{"name":"ABTC Question Text","type":"Alternate Question Text","description":"Does the patient have a history of allergic reactions to any of the study drugs?","url":null,"context":"CTEP"},{"name":"CRF Text5","type":"Alternate Question Text","description":"Does patient have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to ibrutinib or lenolidomide?","url":null,"context":"CTEP"},{"name":"GI_CRF Text 6","type":"Alternate Question Text","description":"Prior allergic reactions attributed to compounds of similar chemical or biologic composition to Gemcitabine or Cisplatin","url":null,"context":"NRG"},{"name":"eligibiity question","type":"Alternate Question Text","description":"Does patient have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to olaparib and cediranib?","url":null,"context":"NRG"},{"name":"ABTC 1603","type":"Alternate Question Text","description":"Does the patient have a history of hypersensitivity or allergic reactions to any of the study drugs?","url":null,"context":"CTEP"},{"name":"CRF Text 6","type":"Alternate Question Text","description":"Does the patient have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to cediranib or olaparib?","url":null,"context":"CTEP"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"Does the patient have a known allergy to cisplatin or compounds of similar biologic composition?","url":null,"context":"NRG"},{"name":"NRG_CRF TEXT 2","type":"Alternate Question Text","description":"Does the patient have a known history of grade 3-4 allergic reaction and/or hepatic toxicity to cisplatin, carboplatin, or gemcitabine?","url":null,"context":"NRG"},{"name":"NRG_eCRF_Text_1","type":"Alternate Question Text","description":"Does patient have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to cediranib, olaparib, AZD5363 (capivasertib), or durvalumab (MEDI4736)?","url":null,"context":"NRG"},{"name":"NRG CRF_Text 3","type":"Alternate Question Text","description":"Does the patient have a history of allergic reactions to compounds of similar chemical or biologic composition to ado-trastuzumab emtansine, trastuzumab, and/or docetaxel (or any of their excipients)?","url":null,"context":"NRG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Does patient have known prior allergy to any of the medications used in protocol therapy?","url":null,"context":"COG"},{"name":"NRG_eCRF_Text_4","type":"Alternate Question Text","description":"Does the patient have a known hypersensitivity to gemcitabine?","url":null,"context":"NRG"},{"name":"NRG CRF Text 1","type":"Alternate Question Text","description":"Does the patient have a history of hypersensitivity to cisplatin or platinum-containing compounds?","url":null,"context":"NRG"},{"name":"NRG_CRF_Text_4","type":"Alternate Question Text","description":"Does the patient have a history of allergic reactions attributed to compounds of similar chemical or biologic composition to olaparib and selumetinib or any excipients thereof?","url":null,"context":"NRG"},{"name":"NRG CRF Text 2","type":"Alternate Question Text","description":"Does the patient have a known history of grade 3-4 allergic reaction or hypersensitivity reaction to cisplatin, carboplatin, or gemcitabine?","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65CB9B0B-A37E-DF66-E040-BB89AD4377E6","latestVersionIndicator":"Yes","beginDate":"2009-03-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-03-23","modifiedBy":"TSESU","dateModified":"2023-09-12","changeDescription":"Replaced VD Chronic Disease Ind-3 (2018845v1) with VD Yes No Unknown Indicator (3506034v1) - dbw","administrativeNotes":"2022.12.20 AQT added for ticket request CADSR0001812. ak","unresolvedIssues":null,"deletedIndicator":"No"}}